Global Parasitic Diseases Therapeutic Market Growth (Status and Outlook) 2025-2031

December 2025 | 71 pages | ID: G8762D49DBEEN
LP Information

Abstracts

According to this study, the global Parasitic Diseases Therapeutic market size will reach US$ million by 2031.

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Parasitic Diseases Therapeutic Industry Forecast” looks at past sales and reviews total world Parasitic Diseases Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected Parasitic Diseases Therapeutic sales for 2025 through 2031. With Parasitic Diseases Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parasitic Diseases Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global Parasitic Diseases Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parasitic Diseases Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parasitic Diseases Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parasitic Diseases Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parasitic Diseases Therapeutic.

This report presents a comprehensive overview, market shares, and growth opportunities of Parasitic Diseases Therapeutic market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Peptides Medicine
• Insect Repellent
• Acaricide
• Other

Segmentation by Application:

• Commercial
• Household

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Pfizer
• Sanaria

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parasitic Diseases Therapeutic Market Size (2020-2031)
  2.1.2 Parasitic Diseases Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Parasitic Diseases Therapeutic by Country/Region (2020, 2024 & 2031)
2.2 Parasitic Diseases Therapeutic Segment by Type
  2.2.1 Peptides Medicine
  2.2.2 Insect Repellent
  2.2.3 Acaricide
  2.2.4 Other
2.3 Parasitic Diseases Therapeutic Market Size by Type
  2.3.1 Parasitic Diseases Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
2.4 Parasitic Diseases Therapeutic Segment by Application
  2.4.1 Commercial
  2.4.2 Household
2.5 Parasitic Diseases Therapeutic Market Size by Application
  2.5.1 Parasitic Diseases Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)

3 PARASITIC DISEASES THERAPEUTIC MARKET SIZE BY PLAYER

3.1 Parasitic Diseases Therapeutic Market Size Market Share by Player
  3.1.1 Global Parasitic Diseases Therapeutic Revenue by Player (2020-2025)
  3.1.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Player (2020-2025)
3.2 Global Parasitic Diseases Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PARASITIC DISEASES THERAPEUTIC BY REGION

4.1 Parasitic Diseases Therapeutic Market Size by Region (2020-2025)
4.2 Global Parasitic Diseases Therapeutic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Parasitic Diseases Therapeutic Market Size Growth (2020-2025)
4.4 APAC Parasitic Diseases Therapeutic Market Size Growth (2020-2025)
4.5 Europe Parasitic Diseases Therapeutic Market Size Growth (2020-2025)
4.6 Middle East & Africa Parasitic Diseases Therapeutic Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Parasitic Diseases Therapeutic Market Size by Country (2020-2025)
5.2 Americas Parasitic Diseases Therapeutic Market Size by Type (2020-2025)
5.3 Americas Parasitic Diseases Therapeutic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Parasitic Diseases Therapeutic Market Size by Region (2020-2025)
6.2 APAC Parasitic Diseases Therapeutic Market Size by Type (2020-2025)
6.3 APAC Parasitic Diseases Therapeutic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Parasitic Diseases Therapeutic Market Size by Country (2020-2025)
7.2 Europe Parasitic Diseases Therapeutic Market Size by Type (2020-2025)
7.3 Europe Parasitic Diseases Therapeutic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parasitic Diseases Therapeutic by Region (2020-2025)
8.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2020-2025)
8.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PARASITIC DISEASES THERAPEUTIC MARKET FORECAST

10.1 Global Parasitic Diseases Therapeutic Forecast by Region (2026-2031)
  10.1.1 Global Parasitic Diseases Therapeutic Forecast by Region (2026-2031)
  10.1.2 Americas Parasitic Diseases Therapeutic Forecast
  10.1.3 APAC Parasitic Diseases Therapeutic Forecast
  10.1.4 Europe Parasitic Diseases Therapeutic Forecast
  10.1.5 Middle East & Africa Parasitic Diseases Therapeutic Forecast
10.2 Americas Parasitic Diseases Therapeutic Forecast by Country (2026-2031)
  10.2.1 United States Market Parasitic Diseases Therapeutic Forecast
  10.2.2 Canada Market Parasitic Diseases Therapeutic Forecast
  10.2.3 Mexico Market Parasitic Diseases Therapeutic Forecast
  10.2.4 Brazil Market Parasitic Diseases Therapeutic Forecast
10.3 APAC Parasitic Diseases Therapeutic Forecast by Region (2026-2031)
  10.3.1 China Parasitic Diseases Therapeutic Market Forecast
  10.3.2 Japan Market Parasitic Diseases Therapeutic Forecast
  10.3.3 Korea Market Parasitic Diseases Therapeutic Forecast
  10.3.4 Southeast Asia Market Parasitic Diseases Therapeutic Forecast
  10.3.5 India Market Parasitic Diseases Therapeutic Forecast
  10.3.6 Australia Market Parasitic Diseases Therapeutic Forecast
10.4 Europe Parasitic Diseases Therapeutic Forecast by Country (2026-2031)
  10.4.1 Germany Market Parasitic Diseases Therapeutic Forecast
  10.4.2 France Market Parasitic Diseases Therapeutic Forecast
  10.4.3 UK Market Parasitic Diseases Therapeutic Forecast
  10.4.4 Italy Market Parasitic Diseases Therapeutic Forecast
  10.4.5 Russia Market Parasitic Diseases Therapeutic Forecast
10.5 Middle East & Africa Parasitic Diseases Therapeutic Forecast by Region (2026-2031)
  10.5.1 Egypt Market Parasitic Diseases Therapeutic Forecast
  10.5.2 South Africa Market Parasitic Diseases Therapeutic Forecast
  10.5.3 Israel Market Parasitic Diseases Therapeutic Forecast
  10.5.4 Turkey Market Parasitic Diseases Therapeutic Forecast
10.6 Global Parasitic Diseases Therapeutic Forecast by Type (2026-2031)
10.7 Global Parasitic Diseases Therapeutic Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Parasitic Diseases Therapeutic Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Parasitic Diseases Therapeutic Product Offered
  11.1.3 Bayer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 F. Hoffmann-La Roche
  11.2.1 F. Hoffmann-La Roche Company Information
  11.2.2 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product Offered
  11.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 F. Hoffmann-La Roche Main Business Overview
  11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Information
  11.3.2 GlaxoSmithKline Parasitic Diseases Therapeutic Product Offered
  11.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GlaxoSmithKline Main Business Overview
  11.3.5 GlaxoSmithKline Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Parasitic Diseases Therapeutic Product Offered
  11.4.3 Pfizer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Sanaria
  11.5.1 Sanaria Company Information
  11.5.2 Sanaria Parasitic Diseases Therapeutic Product Offered
  11.5.3 Sanaria Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanaria Main Business Overview
  11.5.5 Sanaria Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Parasitic Diseases Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Parasitic Diseases Therapeutic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peptides Medicine
Table 4. Major Players of Insect Repellent
Table 5. Major Players of Acaricide
Table 6. Major Players of Other
Table 7. Parasitic Diseases Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Parasitic Diseases Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
Table 10. Parasitic Diseases Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Parasitic Diseases Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)
Table 13. Global Parasitic Diseases Therapeutic Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Parasitic Diseases Therapeutic Revenue Market Share by Player (2020-2025)
Table 15. Parasitic Diseases Therapeutic Key Players Head office and Products Offered
Table 16. Parasitic Diseases Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Parasitic Diseases Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Parasitic Diseases Therapeutic Market Size Market Share by Region (2020-2025)
Table 21. Global Parasitic Diseases Therapeutic Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Parasitic Diseases Therapeutic Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Parasitic Diseases Therapeutic Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Parasitic Diseases Therapeutic Market Size Market Share by Country (2020-2025)
Table 25. Americas Parasitic Diseases Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
Table 27. Americas Parasitic Diseases Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)
Table 29. APAC Parasitic Diseases Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Parasitic Diseases Therapeutic Market Size Market Share by Region (2020-2025)
Table 31. APAC Parasitic Diseases Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Parasitic Diseases Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Parasitic Diseases Therapeutic Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Parasitic Diseases Therapeutic Market Size Market Share by Country (2020-2025)
Table 35. Europe Parasitic Diseases Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Parasitic Diseases Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Parasitic Diseases Therapeutic
Table 41. Key Market Challenges & Risks of Parasitic Diseases Therapeutic
Table 42. Key Industry Trends of Parasitic Diseases Therapeutic
Table 43. Global Parasitic Diseases Therapeutic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Parasitic Diseases Therapeutic Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Parasitic Diseases Therapeutic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Parasitic Diseases Therapeutic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bayer Details, Company Type, Parasitic Diseases Therapeutic Area Served and Its Competitors
Table 48. Bayer Parasitic Diseases Therapeutic Product Offered
Table 49. Bayer Parasitic Diseases Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bayer Main Business
Table 51. Bayer Latest Developments
Table 52. F. Hoffmann-La Roche Details, Company Type, Parasitic Diseases Therapeutic Area Served and Its Competitors
Table 53. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product Offered
Table 54. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. F. Hoffmann-La Roche Main Business
Table 56. F. Hoffmann-La Roche Latest Developments
Table 57. GlaxoSmithKline Details, Company Type, Parasitic Diseases Therapeutic Area Served and Its Competitors
Table 58. GlaxoSmithKline Parasitic Diseases Therapeutic Product Offered
Table 59. GlaxoSmithKline Parasitic Diseases Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. GlaxoSmithKline Main Business
Table 61. GlaxoSmithKline Latest Developments
Table 62. Pfizer Details, Company Type, Parasitic Diseases Therapeutic Area Served and Its Competitors
Table 63. Pfizer Parasitic Diseases Therapeutic Product Offered
Table 64. Pfizer Parasitic Diseases Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. Sanaria Details, Company Type, Parasitic Diseases Therapeutic Area Served and Its Competitors
Table 68. Sanaria Parasitic Diseases Therapeutic Product Offered
Table 69. Sanaria Parasitic Diseases Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Sanaria Main Business
Table 71. Sanaria Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Parasitic Diseases Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parasitic Diseases Therapeutic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Parasitic Diseases Therapeutic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Parasitic Diseases Therapeutic Sales Market Share by Country/Region (2024)
Figure 8. Parasitic Diseases Therapeutic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Parasitic Diseases Therapeutic Market Size Market Share by Type in 2024
Figure 10. Parasitic Diseases Therapeutic in Commercial
Figure 11. Global Parasitic Diseases Therapeutic Market: Commercial (2020-2025) & ($ millions)
Figure 12. Parasitic Diseases Therapeutic in Household
Figure 13. Global Parasitic Diseases Therapeutic Market: Household (2020-2025) & ($ millions)
Figure 14. Global Parasitic Diseases Therapeutic Market Size Market Share by Application in 2024
Figure 15. Global Parasitic Diseases Therapeutic Revenue Market Share by Player in 2024
Figure 16. Global Parasitic Diseases Therapeutic Market Size Market Share by Region (2020-2025)
Figure 17. Americas Parasitic Diseases Therapeutic Market Size 2020-2025 ($ millions)
Figure 18. APAC Parasitic Diseases Therapeutic Market Size 2020-2025 ($ millions)
Figure 19. Europe Parasitic Diseases Therapeutic Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Parasitic Diseases Therapeutic Market Size 2020-2025 ($ millions)
Figure 21. Americas Parasitic Diseases Therapeutic Value Market Share by Country in 2024
Figure 22. United States Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Parasitic Diseases Therapeutic Market Size Market Share by Region in 2024
Figure 27. APAC Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
Figure 28. APAC Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)
Figure 29. China Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 33. India Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Parasitic Diseases Therapeutic Market Size Market Share by Country in 2024
Figure 36. Europe Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
Figure 37. Europe Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)
Figure 38. Germany Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 39. France Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Parasitic Diseases Therapeutic Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Parasitic Diseases Therapeutic Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Parasitic Diseases Therapeutic Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Parasitic Diseases Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 52. APAC Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 53. Europe Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 55. United States Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 56. Canada Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 57. Mexico Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 58. Brazil Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 59. China Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 60. Japan Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 61. Korea Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 63. India Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 64. Australia Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 65. Germany Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 66. France Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 67. UK Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 68. Italy Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 69. Russia Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 70. Egypt Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 71. South Africa Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 72. Israel Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 73. Turkey Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)
Figure 74. Global Parasitic Diseases Therapeutic Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Parasitic Diseases Therapeutic Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Parasitic Diseases Therapeutic Market Size 2026-2031 ($ millions)